S100B, the structural protein of astroglia, has been introduced as a biochemical marker of brain injury in carbon monoxide poisoning. Serum S100B determination is performed in carbon monoxide poisoned patients admitted at the Emergency Department in Ljubljana. An elevated S100B levels in CO-poisoned patients is used as additional criteria for hyperbaric-oxygen therapy, particularly in CO poisoned patients with transitory loss of consciousness.
F.21 Development of new health/diagnostic methods/procedures
COBISS.SI-ID: 18194649Between 2007 and 2011 I managed The Slovenian Register of Intoxications and prepared numerous reports for various users, such as Ministry of Health, Health Insurance Institute, hospitals, physicians, journalists etc. Slovenian register of poisonings offers a continuous review of poisoning in Slovenia and helps us to improve and rationalize antidote supply and therapy of poisonings, including in carbon monoxide poisoning. The Slovenian register of poisoning revealed us that we should consider carbon monoxide poisoning more often
D.01 Chairing over/coordinating (international and national) projects
COBISS.SI-ID: 23807193Neurologic complications increase the morbidity and hospital stays of patients who have otherwise undergone successful operations. We have shown that recombinant human erythropoietin is a promising neuroprotective agent in cardiac operations, since none of the patients in the erythropoietin-treated group had fresh ischemic brain lesions detected by neurological and magnetic resonance imaging examinations. It was confirmed that recombinant human erythropoietin is a promising neuroprotective agent and we recommend it use during operations.
F.21 Development of new health/diagnostic methods/procedures
COBISS.SI-ID: 27885529Oral presentation at the XXVIII international congress of the European Association of Poison Centres and Clinical Toxicologists (Sevilla)
B.03 Paper at an international scientific conference
COBISS.SI-ID: 24858841The balloon-expandable and self-expandable aortic valve prostheses that are deployed at the site of the native aortic valve using special applicators through the peripheral vessels has its advantages and disadvantages compared to the conventional surgical procedure, but current results in selected high risk patients are comparable. With new knowledge, and improved technique and instruments, outcomes can be expected to improve in the future.
F.21 Development of new health/diagnostic methods/procedures
COBISS.SI-ID: 27498713